CYCLACEL PHARMACEUTICALS INC - COM (CYCC) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2020 to Q1 2025

Type / Class
Equity / COM
Symbol
CYCC on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CYCLACEL PHARMACEUTICALS INC - COM (CYCC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$35,979 0
2024 Q4 4,935 $35,979 $7.29 1
2023 Q4 0 $0 -$407,364 0
2023 Q3 1,165,085 $407,364 -$405,924 $0.35 21
2023 Q2 2,064,450 $1,211,253 -$100,417 $0.59 23
2023 Q1 2,237,518 $1,275,183 -$131,091 $0.57 23
2022 Q4 2,454,357 $1,633,300 +$51,283 $0.67 26
2022 Q3 2,327,143 $3,394,000 +$565,749 $1.46 23
2022 Q2 2,106,476 $2,273,000 -$4,356,332 $1.08 20
2022 Q1 3,316,874 $10,116,000 +$276,575 $3.05 24
2021 Q4 3,238,925 $12,584,780 -$2,579,440 $3.89 28
2021 Q3 3,691,029 $19,450,577 -$2,368,802 $5.27 29
2021 Q2 4,084,393 $24,220,881 -$459,457 $5.92 28
2021 Q1 4,108,357 $29,218,197 +$17,249,164 $7.11 32
2020 Q4 1,641,772 $12,821,791 +$8,875,010 $7.81 14
2020 Q3 207,116 $755,965 -$733,655 $3.65 7
2020 Q2 333,819 $1,551,593 +$1,551,593 $4.65 9